|Original language||English (US)|
|State||Published - Aug 2013|
Bibliographical noteFunding Information:
We acknowledge NIH T32 Training grant 5T32HL00706 for funding LBK’s time to complete this project. The funding source had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.
A NIH T32 training grant supported LBK’s fellowship. MTR served as consultant, speaker, advisory board member, and has received research funding from Novo Nordisk, Baxter, Bayer, Biogen Idec, Octapharma, and Pfizer.